CC
Commodore Capital LP disclosed a 5.6% stake in MTRI
Commodore Capital LP reported owning 5.6% of InMed Pharmaceuticals Inc. (MTRI) (2,977,630 shares) in a Schedule 13G filed Nov 13, 2026.
A 13G is a passive stake: the holder does not plan to push for changes.
- Disclosed
- Nov 13, 2026
- Source
- Schedule 13G